Seizures are a presenting feature of many neurosurgical disorders, and can arise as a result of neurosurgical treatment or its complications. Recognition and effective management of seizures can be life-saving, and will minimise long term seizure induced morbidity. In this Element the authors describe seizure diagnosis, emergency and ongoing management, and considerations in neurosurgical conditions.
Central nervous system, affliction, although rare, represents one of the most severe extra-pulmonary manifestations of tuberculosis, potentially leading to substantial morbidity and mortality if not promptly addressed. Cranial tuberculosis can manifest in various forms, including tuberculomas, encephalitis, abscesses, and meningitis, with the latter being the most critical and carrying a poor prognosis if left untreated. […]
Emergency Neurosurgery is a constantly evolving specialty, resulting in ever increasing challenges posed on the higher specialty trainee. The focus of this Element is to guide the reader on the application of robust and easily applicable management strategies whilst dealing with the most challenging aspects of their professional workload. The authors have categorised the various […]
The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in […]
Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) is a clinically important driver alteration affecting approximately one-third of lung cancer patients. Treatments for EGFR-exon 19 deletion and exon 21 L858R NSCLC have evolved over the last decade from first-generation reversible tyrosine kinase inhibitors (TKI) to third-generation irreversible TKIs, of which osimertinib has been […]
KCNQ2 and KCNQ3 encode subunits (KV7.2, KV7.3) that combine to form a voltage-gated potassium ion (K+) channel responsible for generating an ionic current (M-current) important for controlling activity in the nervous system. Pathogenic variants in both genes are associated with a spectrum of genetic neurological disorders that feature epilepsy of variable severity and can be […]
The KRAS oncogene is believed to be the most common single nucleotide variant oncogene in human cancer. Historically, efforts to target KRAS and the other RAS GTPases have struggled. More recently, efforts have focused on identifying and exploiting features unique to specific oncogenic mutations. This has led to the first FDA approval for a RAS […]
Despite considerable advances in our understanding of the biology that underlies tumor development and progression of cancer and the rapidly evolving field of personalized medicine, cancer is still one of the deadliest diseases. Many cancer patients have benefited from the survival improvements observed with targeted therapies but only a small subset of patients receiving targeted […]
This Element serves as a welcome to the Cambridge Elements Genetics in Epilepsy series. The series editors look forward to sharing with you the story of epilepsy genetics through a series of Elements. They will bring together many voices, by text as well as video, to illustrate the history of epilepsy genetics, the many on-going […]